Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro

被引:122
作者
Howard, Douglas B. [1 ]
Powers, Kathleen [1 ]
Wang, Yun [1 ]
Harvey, Brandon K. [1 ]
机构
[1] NIDA, NIH, Mol Neuropsychiat Branch, Neural Protect & Regenerat Sect, Baltimore, MD 21224 USA
关键词
AAV; adeno-associated virus; gene therapy; serotype; tropism; toxicity; neuron; glia;
D O I
10.1016/j.virol.2007.10.007
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recombinant adeno-associated viral (rAAV) vectors are frequently used for gene delivery to the central nervous system and are capable of transducing neurons and glia in vitro. In this study, seven serotypes of a rAAV vector expressing green fluorescent protein (GFP) were characterized for tropism and toxicity in primary cortical cells derived from embryonic rat brain. At 2 days after transduction, serotypes 1 and 5 through 8 expressed GFP predominately in glia, but by 6 days post-transduction expression was neuronal except for AAV5. AAV2 and 9 produced minimal GFP expression. Using cell viability assays, toxicity was observed at higher multiplicities of infection (MOI) for all serotypes except AAV2 and 9. The toxicity of AAV1 and 5-8 affected mostly glia as indicated by a loss of glial-marker immunoreactivity. A frameshift mutation in the GFP gene reduced overall toxicity for serotypes 1, 5 and 6, but not 7 and 8 suggesting that the toxicity was not solely due to the overexpression of GFP. Collectively, a differential tropism and toxicity was observed among the AAV serotypes on primary cortical cultures with an overall preferential glial transduction and toxicity. Published by Elsevier Inc.
引用
收藏
页码:24 / 34
页数:11
相关论文
共 53 条
[1]   The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9 [J].
Akache, Bassel ;
Grimm, Dirk ;
Pandey, Kusum ;
Yant, Stephen R. ;
Xu, Hui ;
Kay, Mark A. .
JOURNAL OF VIROLOGY, 2006, 80 (19) :9831-9836
[2]   Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system [J].
Burger, C ;
Gorbatyuk, OS ;
Velardo, MJ ;
Peden, CS ;
Williams, P ;
Zolotukhin, S ;
Reier, PJ ;
Mandel, RJ ;
Muzyczka, N .
MOLECULAR THERAPY, 2004, 10 (02) :302-317
[3]   Cloning of a novel Apaf-1-interacting protein: A potent suppressor of apoptosis and ischemic neuronal cell death [J].
Cao, GD ;
Xiao, M ;
Sun, FY ;
Xiao, X ;
Pei, W ;
Li, J ;
Graham, SH ;
Simon, RP ;
Chen, J .
JOURNAL OF NEUROSCIENCE, 2004, 24 (27) :6189-6201
[4]   Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain [J].
Cearley, CN ;
Wolfe, JH .
MOLECULAR THERAPY, 2006, 13 (03) :528-537
[5]  
Chen H, 1999, J NEUROSCI RES, V55, P504, DOI 10.1002/(SICI)1097-4547(19990215)55:4<504::AID-JNR10>3.0.CO
[6]  
2-0
[7]   Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors [J].
Chen, SF ;
Kapturczak, M ;
Loiler, SA ;
Zolotukhin, S ;
Glushakova, OY ;
Madsen, KM ;
Samulski, RJ ;
Hauswirth, WW ;
Campbell-Thompson, M ;
Berns, KI ;
Flotte, TR ;
Atkinson, MA ;
Tisher, CC ;
Agarwal, A .
HUMAN GENE THERAPY, 2005, 16 (02) :235-247
[8]   Mediation of BMP7 neuroprotection by MAPK and PKCIN rat primary cortical cultures [J].
Cox, S ;
Harvey, BK ;
Sanchez, JF ;
Wang, JY ;
Wang, Y .
BRAIN RESEARCH, 2004, 1010 (1-2) :55-61
[9]   Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors [J].
Cucchiarini, M ;
Ren, XL ;
Perides, G ;
Terwilliger, EF .
GENE THERAPY, 2003, 10 (08) :657-667
[10]   Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system [J].
Davidson, BL ;
Stein, CS ;
Heth, JA ;
Martins, I ;
Kotin, RM ;
Derksen, TA ;
Zabner, J ;
Ghodsi, A ;
Chiorini, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3428-3432